Conclusions: Although long-term revision rates following total hip replacement were higher among obese patients, we believe that the rates remained acceptable by contemporary standards and were balanced by a lower risk of 90-day mortality.
Level of Evidence: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.
T he outcome of total hip replacement is assessed by various metrics 1 , including revision 2, 3 and increases in mortality above general population rates 4 .
The prevalence of obesity (body mass index [BMI] of ‡30 kg/m 2 ) in the U.S. increased from 12% in 1991 5 to 38% in 2014 6 and in the U.K., from 15% in 1993 to 27% in 2015 7 . Obesity is 
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associated with an increased risk of developing osteoarthritis 8 and undergoing total hip replacement 9 . Several studies have investigated the effect of BMI on revision risk; however, the findings of these studies are not all in agreement. Studies using primary care databases and national registries from the U.K. and New Zealand, ranging from 5,357 to 63,162 patients, have shown variable associations between increased BMI and the risk of revision [10] [11] [12] . Other large cohorts and regional registry studies, ranging from 1,421 to 27,571 patients, have shown no significant association between BMI and revision [13] [14] [15] [16] . Studies assessing the relationship of BMI and mortality at 30 and 90 days have shown mixed results. Four registry studies in the U.S. [17] [18] [19] [20] and a single-center study in the U.K. 21 , with cohorts ranging from 1,744 to 432,841 patients, showed no significant association. Registry studies in Denmark and the U.K., with cohorts of approximately 34,000 and 410,000, respectively, demonstrated a protective effect of being overweight on 30 and 90-day mortality 4, 22 . One small study in Finland showed a protective effect of increasing BMI on mortality risk 23 .
The association between obesity, as measured by BMI, and revision and mortality following total hip replacement is unclear. This is a contentious issue in settings such as the National Health Service (NHS) in the U.K. [24] [25] [26] and the U.S. 27 because of the proposed restriction of total hip replacement according to BMI, although there currently is no restriction by the NHS 28 . Using data from the National Joint Registry (NJR) for England, Wales, Northern Ireland and the Isle of Man, we aimed to investigate the association of BMI with the risk of revision surgery up to 11 years and the risk of 90-day mortality.
Materials and Methods

D
ata were prospectively collected by the NJR in England and Wales from April 1, 2003 to December 31, 2015 . Data were mandatorily collected in the private sector from inception, and in the public sector, from 2011. A recent national audit of data entered into the NJR in 2014 and 2015 estimated data capture of 95% for primary total hip arthroplasty and 91% for revision total hip arthroplasty. Date of death information was provided by the Office for National Statistics.
BMI was recorded for the first time in April 2004, with version 2 of the NJR Minimum Data Set (MDS) data collection form; data collected before that date were therefore excluded. In revision analyses, procedures were also excluded for the following reasons: (1) implausible, very uncommon (<10 or >60 kg/m 2 ), or missing BMI; (2) missing age, sex, or NHS number; (3) unspecified type of hip replacement, operation indication, or bearing type; and (4) performance of total hip replacement due to trauma. In mortality analyses, for patients who underwent same-day bilateral total hip replacement procedures, 1 of the 2 procedures was randomly excluded (Fig. 1) .
The primary exposure was obesity, defined using BMI. BMI was classified according to the World Health Organization (WHO) criteria, as follows: underweight ( ‡10 to <18.5 kg/m 2 ), normal ( ‡18.5 to <25 kg/m 2 ), overweight ( ‡25 to <30 kg/m 2 ), class-I obese ( ‡30 to <35 kg/m 2 ), class-II obese ( ‡35 to <40 kg/m 2 ), and class-III obese ( ‡40 to £60 kg/m 2 ). The primary outcomes were revision following primary total hip replacement and mortality *Descriptive statistics were extracted using the data set to investigate revision (415,598 primary total hip replacements). ‡Descriptive statistics were extracted using the data set of patients excluded from analysis due to "missing or uncommon" BMI (316,717 primary total hip replacements); see Figure 1 . Following the application of the above criteria, the exposure and confounders had no missing values.
Statistical Methods
To describe continuous variables, we use the median and interquartile range (IQR), and for categorical variables, the frequency and percentage.
One minus Kaplan-Meier (1-KM) failure estimates were plotted to describe revision up to 11.75 years and mortality up to 90 days. Time 0 was considered the date of the operation; patients were censored after the first failure was observed, upon death, or administratively censored on December 31, 2015. As *Descriptive statistics were extracted using the data set to investigate revision (415,598 primary total hip replacements). The percentages are of the total number for the given BMI category.
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the numbers at risk in subgroups fell below 100 beyond 10 years of follow-up, the 10-year results are presented to provide reasonable estimates of the 95% confidence intervals (CIs). Log-rank tests were used to compare groups. The association of BMI with revision and mortality was explored using Cox proportional hazards regression models. Multivariable analyses were used to investigate the effect of confounding. Models investigating revision were sequentially adjusted: revision model (RM) 1 was the univariate model, RM 2 adjusted for age and sex, RM 3 further adjusted for ASA grade and year of primary operation, and RM 4 further adjusted for fixation type and indication for operation. Models investigating mortality were also sequentially adjusted: mortality model (MM) 1 was the univariate model, MM 2 adjusted for age and sex, MM 3 adjusted for age and sex and used baseline stratification by indication for operation to allow for nonproportionality, and MM 4 further adjusted MM3 for ASA grade and year of primary operation.
Hazard ratios (HRs), 95% CIs, and p values are reported. Proportional hazard assumptions were investigated graphically using a log-log plot of the survival function.
Analyses were performed with Stata Statistical Software (version 14.2; StataCorp).
Sensitivity Analyses
Two models were fitted to investigate the interaction between BMI and age with respect to revision (RM 5) and mortality (MM 5). Likelihood ratio tests were used to detect significance.
All analyses were repeated using a competing-risks framework, the cumulative incidence function instead of Cumulative probability of revision up to 11 years after primary total hip replacement, with the number at risk at 0, 3, 5, 7, 10, and 11 years, shown by BMI classification. Cumulative probabilities have been multiplied by 100 and are shown as percentages. *The estimates were extracted using the data set to investigate revision (415,598 primary total hip replacements). CI = confidence interval.
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1-KM, and a Fine-Gray model instead of Cox models. In addition, cubic spline models were fitted and compared with the Cox models.
Missing Data
We compared the demographic characteristics for procedures with complete and incomplete BMI data to investigate the potential for systematic biases. In addition, we restricted analyses to data collected in 2008 and onward, when BMI data were more complete.
Results
F
rom April 1, 2003 , to December 31, 2015, 796,636 primary total hip replacements were reported 2 . After applying the exclusion criteria, 415,598 and 413,741 procedures were available for our investigation of revision and 90-day mortality, respectively (Fig. 1) ; follow-up was a maximum of 11.75 years. Each cohort accounted for approximately 52% of the total number of operations; cases with BMI data available were representative of the whole cohort, with the only disparity being the year of primary total hip replacement, which is accounted for in our modeling (Table 1) .
Descriptive statistics were extracted using the revision data set (n = 415,598). Fifty-nine percent of the total hip replacements were performed in female patients. Male patients were slightly younger (Table II) . Sixty-two percent of the patients were nonobese (BMI of <30 kg/m 2 ), and the majority of the patients who were obese (BMI of ‡30 kg/m 2 ) were class-I obese. Females were more prevalent in every BMI category (Table III) . A low ASA grade (P1) was more frequent among underweight, normal, and overweight patients, while the frequency of a higher ASA grade (P4 to P5) was similar across the BMI categories. The fixation type did not vary according to BMI. Figure 2 illustrates the cumulative probability of revision surgery. Increasing levels of obesity were associated with an increased probability of revision (Table IV) . Patients categorized as class-III obese had a 6.7% (95% CI, 5.5% to 8.2%) probability of revision at 10 years after total hip replacement Cumulative probability of revision, with 95% confidence interval, up to 11 years after primary total hip replacement by BMI classification. Cumulative probabilities have been multiplied by 100 and are shown as percentages.
2145
T 19, 2018 compared with 3.3% (95% CI, 2.2% to 4.9%) demonstrated for underweight patients (Fig. 3) . Figure 4 illustrates the probability of 90-day mortality; a log-rank test indicated a significant difference between BMI categories (p < 0.0001): although 90-day mortality was very low for patients in all groups (Table V) , underweight patients had a substantially higher probability of 90-day mortality (1.2% [95% CI, 0.9% to 1.6%]) compared with the other groups (Fig. 5) . Table VI presents the results of the Cox proportional hazards regression analysis for revision. RM 4 shows that class-I, II, and III obese patients were 14%, 30%, and 43% more likely, respectively, to undergo revision compared with patients classified as having a normal BMI. While there was a trend showing that underweight patients were 16% less likely, and overweight patients no more likely, to undergo revision than were patients with a normal BMI, there were no significant differences in the hazard ratios.
Table VII presents the associations between BMI and mortality. Models 1 to 4 indicated strong evidence that underweight patients had higher, and overweight or class-I obese patients had lower, 90-day mortality rates compared with patients classified as having normal BMI. MM 4 showed that the mortality rate of underweight patients was 109% greater than that of normal-BMI patients. Patients classified as either overweight or class-I obese were approximately 30% less likely to die within 90 days of surgery, while classes II and III obese were 21% and 27% less likely, respectively, to die compared with patients classified as having normal BMI. Proportional hazard assumptions were satisfied for all of the models. Cumulative probability of death up to 90 days after primary total hip replacement, with the number at risk at 0, 30, 60, and 90 days, shown by BMI classification. Cumulative probabilities have been multiplied by 100 and are shown as percentages. *The estimates were extracted using the data set to investigate mortality (413,741 primary total hip replacements). CI = confidence interval.
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A greater proportion of underweight patients underwent revision for periprosthetic fracture and adverse softtissue reaction to particulate debris as compared with patients in higher BMI classes. A greater proportion of class-III obese patients who underwent revisions did so for infection (Table VIII) . However, none of these effect sizes Cumulative probability of death, with 95% confidence interval, up to 90 days after primary total hip replacement by BMI classification. Cumulative probabilities have been multiplied by 100 and are shown as percentages. 
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T 19, 2018 were large enough to account for the overall patterns observed.
Sensitivity Analyses
Likelihood ratio tests demonstrated that there was no interaction between BMI and age, either for revision or for mortality. Analyses performed using a competing-risks framework did not alter the interpretation of any of the analyses reported (Fig. 6 , Table IX ). Also, cubic spline models suggested the same outcomes (Figs. 7 and 8 ). The exclusion of operations prior to 2008 yielded the same results as from the main analysis (see Appendix).
Discussion
O ur results demonstrated that long-term revision rates following primary total hip replacement were similar for normal and overweight individuals, but they were higher for patients categorized as class-I, II, and III obese (BMI of ‡30 kg/ m 2 ). Despite this, the revision rates of class-III obese patients remained acceptable by contemporary standards, exceeding the level required for a 10A rating by the Orthopaedic Data Evaluation Panel in the U.K. 29 . The lowest revision rates were observed in the underweight group but the numbers were small and this may therefore be a chance observation. We observed a higher risk of 90-day mortality for underweight patients, with the rate being twice as high as the rate for patients with normal BMI. The rates among overweight and class-I and II obese patients were significantly lower compared with the individuals with normal BMI. Lower mortality rates were observed for those categorized as class-III obese, but again, the numbers were small.
There is little research regarding the influence of BMI on long-term revision risk following primary total hip replacement. Previous studies have used small cohorts and grouped BMI levels rather than using the WHO classification [10] [11] [12] [13] [14] [15] [16] . Analyses have been restricted to particular implants 11, 14 , considered BMI as a continuous variable 10 , or involved only shortterm follow-up [10] [11] [12] 16 . Contrary to our findings, a number of 2148 19, 2018 studies found no association between BMI and revision [13] [14] [15] [16] . These include a single-center study of 3,290 patients that showed no association between obesity and revision risk at a minimum follow-up of 2 years 16 ; the only association seen was between morbid obesity and the risk of infection. Although we observed a higher proportion of class-III obese patients who underwent revision for infection, this difference was not sufficient to account for the overall patterns observed. A regional registry study of 27,571 total hip replacements found no difference in revision rates according to BMI, but did show that a weight of >80 kg was predictive of revision 13 . This finding, limited to men for one indication for revision, is of limited generalizability. In a larger study of 63,162 total hip replacements, a 66% higher rate of revision in morbidly obese patients compared with patients of normal weight was observed, which is greater than the difference observed in our study 10 . A previous study based on a cohort of 5,357 patients in the NJR with a maximum follow-up of 2 years found higher revision rates for the different categories of overweight and obese patients, but none of these findings were significant 12 . In a larger NJR analysis of 17,166 patients who underwent one type of total hip replacement and for whom BMI data were available, a higher rate of revision was observed when patients with a BMI of >30 kg/m 2 were compared with patients with a lower BMI 11 . Cumulative incidence function of revision up to 11 years after primary total hip replacement, adjusting for the competing risk of death separately for each BMI classification.
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Our group previously observed a protective effect of being overweight when the risk of mortality following primary total hip replacement was considered 4 . In the current study, we observed a significantly lower risk of mortality among overweight and class-I and II obese patients compared with those of normal BMI. No significant difference between class-III obese patients and patients with a normal BMI was observed. The highest rates of mortality were observed in the underweight group. This protective effect of increasing BMI was also seen in a single-center study of 756 primary total hip replacements, although nonstandard groupings were used and the findings were not significant 23 . Data from the Danish registries demonstrated significantly higher mortality among patients classified as underweight and as having normal BMI compared with overweight patients and suggested that a BMI of 27 to 28 kg/m 2 was associated with the lowest risk of mortality 22 . In contrast with these findings and those of the current study, analyses of U.S. registry data and a single-center study of 1,744 patients in the U.K. demonstrated no significant association between BMI and the risk of mortality [17] [18] [19] [20] [21] . The "obesity paradox," whereby being overweight or obese offers a protective effect against adverse outcomes or mortality, has been observed in cardiac 30, 31 , oncologic 32 , and surgical fields 33 .
There is a risk of bias when considering the influence of BMI on outcomes such as mortality; the risk of collider bias through mediators such as diabetes does not explain the observation, and alternative causative explanations require further investigation 34 . Although those who are underweight may have comorbidities or other illnesses to explain low BMI, the population considered is screened for fitness to undergo surgery (the "healthy patient-selection effect") and therefore we do not believe that illness in the underweight group explains the higher mortality, particularly as our models adjusted for ASA grade. Smoking is a potential confounding factor that has been identified among patients with cardiovascular disease that may at least partially explain observed mortality patterns and requires further investigation 35 . 
